← FDA DRUG APPROVALS

FDA ANDA · ANDA207059

LIDOCAINE

Sponsor: USPHARMA

APPLICATION
ANDA207059
TYPE
ANDA
ORIGINAL APPROVAL
2026-02-09
LATEST ACTION
2026-02-09
ROUTE
TOPICAL
DOSAGE FORM
PATCH
MARKETING STATUS
Prescription

Products

LIDOCAINEPrescription
LIDOCAINE 5% · PATCH · TOPICAL

Approval history

2026-02-09UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →